亚利桑那州农村地区的Helicobacter pylori抗生素耐药率:基于分子的研究
Fernando P Monroy1,2, Heidi E Brown3, Claudia M Acevedo-Solis1
1Department of Biological Sciences, College of the Environment, Forestry and Natural Sciences, Northern Arizona University, 617 South Beaver Street, Flagstaff, AZ 86011, USA.
Microorganisms
|September 28, 2023
概括
杆菌 (H. pylori) 的抗生素耐药性是一个日益关注的问题,特别是在农村土著社区. 这项研究发现耐药性突变的高率,突出了针对性治疗策略的需要.
科学领域:
- 医学微生物学 医学微生物学
- 传染性疾病 传染性疾病
- 遗传学 遗传学 是一个
背景情况:
- 杆菌 (H. pylori) 感染是胃癌的主要原因.
- 全球范围内,H. pylori的抗生素耐药性正在增加,这给治疗带来了挑战.
- 关于美国农村土著人口中H. pylori抗生素耐药性的数据有限.
研究的目的:
- 在亚利桑那州北部的美国印第安人患者中调查H. pylori中抗生素耐药性突变的患病率.
- 为了识别与克拉里胺和甲尼达抗性相关的特定突变.
主要方法:
- 从67名H.pylori阳性内镜患者的胃活检样本进行了测序.
- 分析的重点是23S核糖体RNA (23S) 和对氧不敏感的NADPH氧还原酶 (rdxA) 区域的耐药性突变.
- 检查患者病史和内镜检查结果的医疗记录.
主要成果:
- 在49名没有先前感染过H. pylori的个体中,38.8%患有克拉里素耐药突变 (T2182C最常见).
- 耐美特醇突变非常普遍 (93.9%),其中D95N和L62V是最常见的.
- 在抗性突变患病率上没有观察到基于性别的显著差异.
结论:
- 在这个农村土著人口中观察到H. pylori抗生素耐药性突变的高率.
- 这些发现强调了需要考虑耐药性概况来有效治疗H. pylori的必要性.
- 该研究强调了耐药性测试的重要性,特别是考虑到H. pylori的高流行率和低测试率.
相关概念视频
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
435
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
435
Development of Antibiotic Resistance
33
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
33
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
154
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
154
Antibiotic Selection
54.6K
Overview
54.6K


